11th Annual Oncology Innovation Forum

FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT

10th of January 2026|MARINES' MEMORIAL CLUB | SAN FRANCISCO | USA

Attendees:

1824 Health Ventures

3i Partners Fund II LLC

7 Hills Pharma Inc.

9vc

AAA Family Office

AAVivo Inc.

Abdera Therapeutics

Ability Pharmaceuticals, SA

Accequa

Accession Therapeutics Ltd.

adMare BioInnovations

AdvanCell Pty Ltd.

Advantary Capital Partners

Age1 Capital Management, LLC

Aleta Biotherapeutics

Alfidi Capital

Alignment Ventures

Alithia Life Sciences Pty Ltd

Alix Ventures

Angelini Ventures S.p.A.

Angels + Life.Sci Investors Network NJAngels.net

Aqua Partners LLC

Aquillius Ventures

Araris Biotech AG

Arcellx, Inc.

Argobio Studio

Ascensus Therapeutics, Inc.

Astellas Pharma, Inc.

Astellas Venture Management LLC

AstraZeneca

Asymchem Fund

ATEM Capital

Athyrium Capital Management, LP

Atlas Capital Ventures LLC

Autolus Therapeutics PLC

Awen GmbH

Barclays

Bayland Capital

Beijing Zhaode Investment Co Ltd

BERNINA BioInvest Ltd.

BFC Group

Bio Med Gene Ventures

Biocell Ltd

Biomunex Pharmaceuticals

Biond Biologics Ltd.

Bioqube Ventures

Bioscience Equity Partners

BIOSTART Consulting GmbH

Biotechgate

Blood Cancer United

Bluezone Capital

BOHE Angel Fund

BradleyWoods&Co. Ltd

Branch Therapeutics, Inc.

Breslin AG

Brookline Capital Markets

BTIG, LLC

Canaccord Genuity

Cancer Focus Fund

Cancer Research Institute, Inc.

CapsicoHealth, Inc.

CBT Advisors

CDR-Life AG

Cellectar Biosciences, Inc.

CITICS CLSA Capital Partners HK Ltd

ClavystBio

Clear Street LLC

Cohesion Bureau

Convergence Partners

Cornell University

CTI LSF

Cukierman & Co. Life Sciences

Cullinan Therapeutics, Inc.

Davis Polk & Wardwell LLP

DB Capital, LLC

DCVC Bio

DeBere Capital Partners

DFB Pharmaceuticals, LLC

DigiTx Partners

Eight Bridges

Eight Roads Ventures

Eisai Innovation Inc.

Eli Lilly and Company

Elmstead Partners LLC

Emory Drug Development Fund

Endeavor Venture Fund

Erasca, Inc.

ESC Advisors

Fenix Group International, LLC

Ferghana Partners, Inc.

Flagship Pioneering

Fontaine Capital

Forbion

Fortlane Partners Corporate Finance GmbH

FreeMind Group

Geneer Partners

Generation Fund Life Sciences Fund I

Genesis Capital III

GSK

H.C. Wainwright & Co., LLC

Hanne Capital

Health Innovation Capital

HHS - ASTP/ONC

Horizon 3 Healthcare

Hunniwell Lake Ventures, LLC

IAG Capital Partners

ID3 Ventures

Immunophotonics, Inc.

Indaco Venture Partners SGR S.p.A.

Ingenious Global Venture Partners

Institute for Follicular Lymphoma Innovation (IFLI)

Intermediate Capital Group PLC

Intsel Chimos

IPF Partners

Ipsos Healthcare Advisory Service

Iterion Therapeutics, Inc

J.P. Morgan

Jeito Capital

Johnson & Johnson Innovation – JJDC, Inc.

Johnson & Johnson Innovation LLC

Junson Capital

Kallisio Inc.

Kicker Ventures

Klayon Therapeutics, Inc.

L.E.K. Consulting

L.E.K. Consulting LLC

Labcorp Drug Development

Ladenburg Thalmann & Co. Inc.

Landmark Agels Inc. Family Office

Laverock Therapeutics Ltd.

Lazard Ltd.

Lifespan Vision Ventures LLC

Lilly Asia Ventures

LongRiver Investments

Lumanity

Lumira Ventures

Lynx Financial Hong Kong Ltd.

M Ventures

Marigold Investment Management

Medicines Discovery Ventures

Merck KGaA, Darmstadt, Germany

Merrill Lynch

Mianus Capital LLC

Mizuho Securities Co., Ltd.

MM Family Office

Momentum Biotech

Morningside Venture Capital

MPC Investment

Myeloma Investment Fund (MIF)

NanOlogy LLC

National Institutes of Health (NIH)

NAYA Therapeutics

NEOK Bio, Inc.

NEUROBILT Partners

New Harbor Venture Partners, LLC

New Science Fund

NFX

Nomal Therapeutics

Novartis AG

Novartis Pharma AG

o2h Ventures Ltd.

Observa Capital

OCA Ventures

Oncode Accelerator

Ontario Teachers' Pension Plan

Oppenheimer & Co. Inc.

Oracle

Oxford Science Enterprises

OxSonics

Palo Alto Investors

Palo Santo Fund

Panacea Venture

Pathios Therapeutics Ltd.

Perspective Therapeutics

Pfizer, Inc.

Pharmaphorum Media Limited

Pilatus Biosciences SA

Piper Sandler & Co.

Plaisance Capital

Playground Global

PMK-Ventures Pte. Ltd.

Porton Pharma Solutions

PPD

Prevail Partners LLC

Pullan Consulting

Qiming Venture Partners

Quata Confidence Capital

Ratio Therapeutics

RayzeBio, Inc.

RefinedScience

Remiges Ventures, Inc.

RiverVest Partner

Ryvu Therapeutics S.A.

Samsung Bioepis

SciTech Development LLC

Seqens

Shanghai Healthcare Capital

Sherpa Healthcare Partners

Shionogi Inc.

Sifr Capital

Silicon Valley Venture Growth Partners

SOTIO Biotech a.s.

SPRIND GmbH

Star Tree Ventures Ltd.

SternAegis Ventures

Stingray Therapeutics

SummitBio Advisory

Taiho Ventures, LLC

Tailwinds Ventures

The Benchmark Company, LLC

The Fulford Group Ltd.

The Global Emerging Markets Group (GEM)

The Venture Collective, LLC

Tin Alley Ventures Pty. Ltd.

TOLREMO Therapeutics AG

Toray Industries, Inc.

Two Sigma Ventures

Umlaut.bio GmbH

V-Bio Ventures

Vickers Venture Partners

Vitarka Therapeutics Ltd

VSPharmTech Co., Ltd.

WBB Securities, LLC

Wellington Partners

WRF Capital

Zymeworks Inc.

Last updated: April 3, 2026